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Abstract
Background: Ten-eleven translocation (TET) enzymes oxidise DNA methylation as part of an active demethylation
pathway. Despite extensive research into the role of TETs in genome regulation, little is known about their effect on
transposable elements (TEs), which make up nearly half of the mouse and human genomes. Epigenetic mechanisms
controlling TEs have the potential to affect their mobility and to drive the co-adoption of TEs for the benefit of the host.
Results: We performed a detailed investigation of the role of TET enzymes in the regulation of TEs in mouse embryonic
stem cells (ESCs). We find that TET1 and TET2 bind multiple TE classes that harbour a variety of epigenetic signatures
indicative of different functional roles. TETs co-bind with pluripotency factors to enhancer-like TEs that interact with
highly expressed genes in ESCs whose expression is partly maintained by TET2-mediated DNA demethylation. TETs
and 5-hydroxymethylcytosine (5hmC) are also strongly enriched at the 5′ UTR of full-length, evolutionarily young LINE-1
elements, a pattern that is conserved in human ESCs. TETs drive LINE-1 demethylation, but surprisingly, LINE-1s are kept
repressed through additional TET-dependent activities. We find that the SIN3A co-repressive complex binds to LINE-1s,
ensuring their repression in a TET1-dependent manner.
Conclusions: Our data implicate TET enzymes in the evolutionary dynamics of TEs, both in the context of exaptation
processes and of retrotransposition control. The dual role of TET action on LINE-1s may reflect the evolutionary battle
between TEs and the host.
Keywords: Embryonic stem cells, Retrotransposons, LINE-1, DNA methylation, Hydroxymethylation, Ten-eleven
translocation enzymes, Enhancers
Background
Transposable elements (TEs) are mobile genetic elements
that are present in organisms from all kingdoms of life
and account for nearly half of the human and murine
genomes. Retrotransposons, which act through an RNA
intermediate, are recognised as major evolutionary
contributors to genome structure and organisation.
Namely, retrotransposons bear enormous potential for af-
fecting gene expression at multiple levels, from creating
novel transcription factor (TF) binding sites to regulating
post-transcriptional processes [1, 2]. The co-adoption, or
exaptation, of TEs by the host genome is often associated
with the creation of species-specific cis-acting elements
that help to shape gene regulatory networks [1, 3]. In
embryonic stem cells (ESCs), long-terminal repeat (LTR)
TEs (also termed endogenous retroviruses; ERVs) have
made a substantial contribution to the distribution of bind-
ing sites for pluripotency factors across both human and
mouse genomes [4, 5], and the expression of HERVH TEs
is required to safeguard the identity of human ESCs [6, 7].
On the other hand, active TEs such as LINE-1 (or L1)
elements carry substantial mutagenic potential, as
evidenced by numerous examples of disease-causing ret-
rotransposition events [8]. Somatic retrotransposition of
L1s has also been linked to disease, especially in the con-
text of cancer [9, 10]. Mobility restriction of these
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elements is therefore of paramount importance to
maintain genome stability, especially during the crucial
developmental windows of germline establishment and
early embryogenesis. Notably, both human ESCs and
induced pluripotent stem cells (iPSCs) support L1
mobility [11] and de novo retrotransposition events from
endogenous TEs have been detected in clonally derived
iPSCs [12], with important implications for regenerative
medicine strategies.
During early embryogenesis, TEs are kept under
control by multiple epigenetic mechanisms such as DNA
methylation, histone modifications and small RNA-
mediated mechanisms [13]. The large and rapidly evolving
family of Krüppel-associated box domain-containing zinc
finger proteins (KRAB-ZFPs) play a major role in ERV
silencing by recruiting the cofactor KRAB-associated
protein 1 (KAP1), which acts as a docking protein for
heterochromatin-forming activities, including the H3K9
methyltransferase SETDB1 [14, 15]. Interestingly, KRAB-
ZFPs have also been implicated in the silencing of old L1
elements, acting as major drivers of L1 evolutionary
dynamics [16, 17]. In contrast, Piwi-interacting RNAs
(piRNAs) are important for silencing of young, active L1s
in humans iPSCs [18]. DNA methyltransferases, which
can act downstream of piRNA action, also play a crucial
role in the repression of young L1 families in both mouse
and human ESCs [15, 16, 19]. However, DNA methylation
(5-methylcytosine; 5mC) undergoes genome-wide erasure
during preimplantation development [20], creating a
potential window of opportunity for TE expression. While
the primary mechanism underlying DNA demethylation
in this period is replication-coupled dilution of 5mC
[21, 22], an active mechanism dependent on ten-eleven
translocation (TET) enzymes has also been demonstrated
for specific loci [23–25]. TETs catalyse the iterative oxida-
tion of 5mC to 5-hydroxymethylcytosine (5hmC), 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC), with
the latter two bases being substrates for TDG-dependent
repair mechanisms that reintroduce unmodified cytosines
into the genome [26]. TET enzymes can also modulate
transcription in a non-catalytic way by recruiting other
chromatin regulators, such as OGT (O-linked β-d-N-acet-
ylglucosamine (O-GlcNAc) transferase) [27], the SIN3
co-repressor complex [28] and the Polycomb repressive
complex 2 (PRC2) [29]. Unlike TET-mediated DNA
demethylation, the interaction with these proteins can
have repressive outcomes, underlying a dual nature of
TET action in ESCs [28, 30].
We have previously shown that L1 elements are
enriched in 5hmC in mouse ESCs [31, 32], raising the
possibility that TET enzymes regulate their transcription.
However, a wider and functional investigation of the role
of TET enzymes at TEs is missing. Here we asked
whether TET enzymes regulate the action of TEs, both
as exapted regulatory elements and as mutagenic mobile
elements. We found that TETs bind to multiple TE
families, including TE-derived ESC-specific enhancers,
which are kept hypomethylated in part by the action of
TET2, thus helping to maintain the expression of associ-
ated genes. We also show that TETs demethylate young
L1 elements but that their expression levels are stably
maintained upon TET depletion due to the loss of TET--
dependent repressive activities, such as SIN3A. Our
findings implicate TET enzymes in the evolution of the
TE-host relationship, contributing to exaptation pro-
cesses and forming a hub for the so-called evolutionary
arms race.
Results
TET1 binds to repetitive elements with diverse chromatin
signatures
Previous studies have established that TET1 primarily binds
at CpG-rich gene promoters in mouse ESCs [28, 30]. How-
ever, a thorough investigation of TET1 binding to repetitive
elements was not conducted. To test whether TET1 binds
to particular repeat classes, we uniquely mapped chromatin
immunoprecipitation (ChIP) sequencing data [28] and
calculated the proportion of TET1 peaks that overlapped
each repeat class within the RepeatMasker annotation.
When compared to a random control, several repeat classes
were found to be significantly enriched for TET1 peaks,
which included L1 elements, IAPEYs and a number of
other LTR elements (Fig. 1a; Additional file 1). Similar
results were obtained when we also included non-uniquely
mapped reads, which can nonetheless be assigned a par-
ticular repeat class (Additional file 1). This ‘inclusive map-
ping’ strategy assigns reads with multiple hits of equal
mapping quality to one of those locations at random and is
useful to assess overall patterns of repeat classes with low
mappability. We therefore used inclusive mapping on pub-
licly available epigenomic data to characterise the identified
TET1 targets. Interestingly, we found that TE-associated
TET1 binding sites display markedly different chromatin
compositions depending on TE class (Fig. 1b; Additional
file 2: Figure S1A). TET1 peaks at L1 elements (L1Md_T,
L1Md_A, L1Md_Gf) showed a pronounced enrichment for
H3K4me3, a mark associated with active gene promoters,
which is reminiscent of that seen in TET1-bound CpG-rich
promoters. At IAPEY elements TET1 binding occurs in a
region that is not enriched for H3K9me3 (Fig. 1b) and it is
possible that more overt TET1 binding is impaired by the
strong H3K9me3 enrichment seen elsewhere throughout
these elements [33]. RLTR46 elements were enriched for
CTCF, as previously reported [5], raising the possibility that
TET1 activity at these TEs may help to maintain a hypo-
methylated state that is permissive for CTCF binding
[34, 35]. Finally, we found that TET1 peaks overlapping a
number of LTR elements (e.g. RLTR13D6, RLTR9D) were
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associated with marks of active enhancers (H3K27ac,
p300), consistent with an enrichment of 5hmC at enhan-
cer elements [34]. Moreover, these TE classes are bound
by the pluripotency factors NANOG, OCT4 and SOX2
(collectively referred to as NOS from here onwards), as
previously reported [5], suggesting that maintenance of an
ESC-specific gene expression programme may be aided by
TET1 binding to TE-derived enhancers. Analysis of ChIP-
sequencing data for TET2 [36], which is also expressed in
ESCs, showed that a subset of the TEs targeted by TET1
are seemingly also bound by TET2 (Additional file 2: Fig-
ure S1B). Altogether these data show that TET enzymes
binds to multiple TEs in ESCs, with potentially different
functional outcomes depending on the underlying epigen-
etics of each TE class.
TET2 helps to maintain gene expression driven by TE-
derived enhancers
To investigate the putative role of TETs at TE-derived
ESC enhancers, we first analysed uniquely mapped
ChIP-seq data at individual copies of TE classes associ-
ated with TET1 and NOS. TET1 binding was strongly
correlated with the levels of both enhancer-associated
histone marks (H3K4me1, H3K27ac) and NOS (Fig. 2a).
As enhancers regulate gene expression through direct
contact with promoters, we also analysed three-
dimensional chromatin conformation data from promoter
capture Hi-C experiments [37]. We found that NOS-
bound TE-derived enhancers were more likely to make
contacts with gene promoters than their NOS-unbound
counterparts (Fig. 2a). Importantly, genes interacting with
NOS-bound TEs were expressed at higher levels than
those interacting with NOS-unbound TEs of the same
classes (Fig. 2b). RNA sequencing (RNA-seq) analysis on
rRNA-depleted samples revealed short bidirectional
enhancer RNAs (eRNAs) generated at NOS-bound TEs
(Fig. 2c), adding further support to their role as active
enhancers [38]. To test whether TET enzymes helped to
maintain the activity of TE-derived enhancers, we
depleted TET1 or TET2 in ESCs via lentiviral delivery of
shRNAs. We first confirmed by ChIP that both TET1 and
TET2 are enriched at TE classes associated with enhancer
marks, with binding being lost upon depletion of TET1 or
TET2 (Fig. 2d). We then performed RNA-seq to ask
whether the expression of genes interacting with TE-
derived enhancers was affected by TET depletion. Upon
TET2 depletion there was a mild but significant downreg-
ulation of genes interacting with NOS-positive TEs
(Fig. 2e). To test whether the effects of TET2 on enhancer
activity were associated with changes in 5mC and/or
5hmC, we analysed BS-seq (which measures 5mC +
5hmC) and TAB-seq (which measures 5hmC) data from
TET KO ESCs [39]. We found that NOS-positive TE
copies had strikingly lower levels of 5mC than their NOS-
negative counterparts, as expected from their enhancer
activity (Fig. 2f). TET2 KO led to a more dramatic
decrease of 5hmC at both groups of TEs than TET1 KO
(Fig. 2g) and this was coupled with a specific increase in
5mC levels at NOS-positive TEs (Fig. 2f), which is in
agreement with the gene expression data. These data show
that TET enzymes help to maintain the expression of
NOS-regulated genes by targeting specific retroelement
classes and suggest that this occurs in a DNA
methylation-dependent manner.
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TETs and 5hmC are enriched at the 5′ UTR of young L1
elements
To analyse in more detail the binding of TET1 to L1
elements, we mapped the TET1 ChIP-seq data to a
highly active L1Tf element (L1Orl [40]), which revealed a
striking enrichment of TET1 at the 5′ UTR of the elem-
ent that was lost upon TET1 depletion (Fig. 3a). To val-
idate and extend these findings, we first performed
ChIP-qPCR on WT and TET-depleted ESCs, showing
that both TET1 and TET2 bind to the 5′ UTR of L1A,
L1Tf and L1Gf elements (Fig. 3b). We then investigated
TET1 binding across different L1 subfamilies, ordering
them by evolutionary age [16, 41]. Only full-length
(>5 kb), evolutionarily young L1 elements had a substan-
tial fraction of copies (5–10%) overlapping unique TET1
peaks (Fig. 3c). While many short L1Gf elements also
appear to be bound by TET1, these are poorly annotated
fragments that are often part of longer L1 copies. Given
the difficulty in uniquely mapping ChIP-seq data to
young L1s, we also calculated the overlap with TET1
peaks generated by inclusive mapping. We have termed
these peaks ‘ambiguous’, as they cannot be confidently
assigned to a specific copy when dealing with young L1s,
but nonetheless reveal the maximum number of copies
that may be TET1 bound. This strategy showed that
nearly 80% of L1Gf, L1A and L1Tf elements have the po-
tential to bind TET1 (Fig. 3c). Interestingly, the emergence
and expansion of these young L1 families coincides with a
loss of the repressive action of KAP1, which targets older
L1s [16]. TET binding could constitute an additional
mechanism by which young L1 elements have overcome
the repressive mechanisms of the host. To test the
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involvement of TET binding in DNA methylation turn-
over at L1s, we analysed the levels of 5hmC throughout
L1Orl, which revealed an enrichment at the 5′ UTR,
matching the pattern of TET1 binding (Fig. 3d). Moreover,
TET1-bound L1Tf copies display lower 5mC levels (and
concomitantly higher 5hmC levels) than TET1-unbound
copies (Fig. 3e), a pattern that is also found in other
TET1-bound TE classes (Additional file 2: Figure S2).
Analysis of 5fC and 5caC enrichment data [42] further re-
vealed that, upon TDG depletion, these two marks sub-
stantially accumulate at the 5′ UTR of L1Orl (Fig. 3f),
showing that L1 elements undergo replication-
independent DNA demethylation via 5mC oxidation.
We then asked whether a similar mechanism could be
implicated in the regulation of human L1 elements.
Using TAB-seq data from human ESCs [34], we uncov-
ered a remarkably similar pattern of 5hmC at a highly
active human L1 (L1.4 [43]), whereby the 5′ UTR
displayed relatively high levels of this mark (Fig. 3g).
Moreover, 5hmC enrichment across human L1 families
mirrored our observations in the mouse, showing that
only young, KAP1-unbound elements were enriched for
5hmC and this was accompanied by a decrease in 5mC
levels (Fig. 3h). These observations show that, along in-
dependent evolutionary paths, L1 elements recruited
TET enzymes and accumulated 5hmC at their 5′ UTR
in a manner that correlates with their activity.
TET-mediated L1 demethylation has no overall effect on
expression
The above data suggest that TET enzymes help to main-
tain L1 elements relatively hypomethylated in ESCs. We
therefore measured 5mC and 5hmC levels at the 5′
UTR of L1s in TET-depleted ESCs using deep sequen-
cing of amplicons from oxidative bisulfite (oxBS)-treated
DNA [32, 44]. TET1 depletion led to a decrease of
5hmC at young L1 elements (L1Tf, L1A, L1Gf), which
was accompanied by a significant increase in 5mC levels
at L1A and L1Gf elements (Fig. 4a). TET2 depletion had
a more dramatic effect for all three L1 classes, leading to
a complete loss of 5hmC and an increase of 5mC levels
of around 10% (Fig. 4a). To test for redundancy between
the two TET enzymes, we performed double knockdown
(DKD) of TET1 and TET2 and measured 5mC/5hmC
levels. Compared to TET2 depletion alone, DKD did not
lead to an additional increase in 5mC levels (Fig. 4b).
We also analysed TAB-seq data from WT, Tet1 KO and
Tet2 KO ESCs [39], which showed that the changes in
5mC/5hmC levels are largely restricted to the 5′ UTR
region of L1Tf elements, and corroborated the increase
in 5mC levels in both TET1- and TET2-depleted cells
(Additional file 2: Figure S3A and B). Finally, we re-
analysed BS-seq data from WT and Tet1/Tet3 double
knockout blastocysts, confirming that TETs maintain L1
hypomethylation in vivo (Additional file 2: Figure S3C)
[45]. These data show that TET1 and TET2 are major
regulators of DNA modifications at young L1s, helping
to maintain low 5mC.
Given that loss of DNA methylation in DNMT KO
ESCs leads to L1 derepression [15, 19], we predicted that
TET depletion would cause a downregulation of L1s.
Surprisingly, however, quantitative reverse transcription
polymerase chain reaction (RT-qPCR) analyses showed
that the expression levels of L1 elements were unaffected
in TET1-depleted or TET2-depleted ESCs, both at four
and ten days after lentiviral infection (Fig. 4c). L1 ex-
pression was also stable upon DKD of both TETs
(Fig. 4c). Analysis of our RNA-seq data supported these
observations and further revealed that no TET1-bound
TE classes were deregulated in TET-depleted ESCs
(Additional file 2: Figure S4A and B); in contrast, sub-
stantial changes in the expression of single-copy genes
were readily detectable (Additional file 2: Figure S4C).
RNA-seq data from WT and Tet1/Tet3 double knockout
blastocysts further supported these findings (Additional
file 2: Figure S4D) [45]. In line with the RNA data, we
detected no alterations in the levels of ORF1p protein
(Fig. 4d). Additionally, using northern blot we found no
significant differences in the levels of full-length L1Tf el-
ements (Fig. 4e). We considered the possibility that
changes in the expression of individual L1 copies that
gained 5mC may be undetectable when analysing the
whole L1 RNA pool. To test this hypothesis, we
designed specific primers for RT-qPCR and oxBS that
target three individual full-length L1 loci in the mouse
reference genome (referred to here as HL1-2, HL1-6 and
HL1-7; see ‘Methods’ for details). All tested L1 copies
showed a significant increase in 5mC levels upon DKD
(See figure on previous page.)
Fig. 4 L1 expression is maintained upon TET-mediated demethylation. a Deep amplicon sequencing from oxBS-treated DNA was used to measure
5mC and 5hmC levels at young L1s in WT and TET-depleted ESCs; each data point represents the average value from three biological replicates at a
given CpG within the amplicon. b Double TET1/TET2 knockdown does not lead to more pronounced effects on 5mC/5hmC than TET2 knockdown
alone. c Quantitative reverse transcription polymerase chain reaction (RT-qPCR) data of TET1- and/or TET2-depleted ESCs, at four or ten days following
lentiviral shRNA delivery (n = 6); no statistically significant differences are detected (t-test). dWestern blot for ORF1p also shows no difference in expression
at the protein level. e Representative northern blot for L1Tf, with averaged data from n= 4 quantified on the right; no statistically significant differences in
the levels of full-length L1Tf are detected (t-test). f RT-qPCR (n = 6) and oxBS (n = 3) analysis of individual L1 copies reveals a similar pattern to that seen in
the pool of all L1s, with no expression differences despite increased 5mC levels. * p< 0.05, *** p< 0.001, ANOVA with post-hoc Tukey test
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of both TETs or single knockdown of TET2, with two of
them also displaying changes upon TET1 depletion
(Fig. 4f ). Despite these differences, none of these L1 cop-
ies had significantly altered expression levels upon
depletion of TET1, TET2 or both enzymes (Fig. 4f ).
Overall, these results demonstrate that TET-mediated
changes in DNA methylation at L1s do not translate into
expression differences, indicating that although DNA
methylation is an important regulator of L1 repression
in ESCs, other layers of regulation can play equally
prominent roles.
TET-dependent epigenetic activities keep L1s repressed
The above data raised the possibility that additional
mechanisms compensate for changes in DNA methyla-
tion in TET-depleted cells to ensure L1 repression.
Given the known involvement of small RNAs in human
L1 regulation [18, 46], we first asked whether small RNA
pathways could underlie the stability of L1 expression
levels in TET-depleted cells. Small RNA-seq of WT and
TET-depleted cells revealed no differences in the
amount of L1-derived small RNAs (Additional file 2:
Figure S5), suggesting that these pathways are not
directly involved in the maintenance of L1 RNA levels
upon TET depletion. We next asked whether TET
enzymes regulate other aspects of L1 chromatin. We
used ChIP-seq data from Tet1 and Tet2 KO ESCs
and assessed the levels of several histone modifica-
tions at L1-associated TET1 binding sites (Additional
file 2: Figure S6A). The most notable change was a
loss of H3K9me3 in Tet2 KO ESCs, which we vali-
dated by ChIP-qPCR in our knockdown cells (Fig. 5a;
Additional file 2: Figure S6B). Loss of H3K9me3 at
L1s, which is deposited by SUV39H, leads to tran-
scriptional derepression [47], potentially counteracting
the increase in 5mC in TET2-depleted cells. In Tet1
KO cells, however, no pronounced alterations in the
levels of the tested histone modifications were seen in
ChIP-seq data (Additional file 2: Figure S6A). Indeed,
by ChIP-qPCR we could only detect a relatively minor loss
of H3K4me3 at L1 elements upon TET1 depletion (Fig. 5a;
Additional file 2: Figure S6B), as well as impaired OCT4
binding (Additional file 2: Figure S6C). Both of these
changes would be expected to further contribute to L1
downregulation upon TET1 depletion, together with
increased 5mC.
We argued that any compensatory repressive mechan-
ism that depends on TET1 is likely to be mediated by
known interacting partners, namely OGT, SIN3A and
the PRC2 complex [27–29]. Publicly available ChIP-seq
data revealed that both OGT and SIN3A are enriched at
the 5′ UTR of L1 elements, while members of the PRC2
complex are undetectable (Fig. 5b). We confirmed the
enrichment of OGT and SIN3A at the 5′ UTR of young
L1s by ChIP-qPCR (Fig. 5c). To test the effect of OGT
on L1 expression, we depleted ESCs of OGT by siRNA,
which led to a global loss of O-GlcNAc (Fig. 5d). Inter-
estingly, OGT depletion caused an upregulation of L1 el-
ements and this effect was partly dependent on TET1
expression (Fig. 5e). We confirmed that L1 derepression
involved full-length elements and that ORF1p protein
levels were also raised (Additional file 2: Figure S7A and
B). However, we noted that TEs that are not bound by
TET1 were also derepressed, suggesting that the effect
of OGT depletion on L1s may be indirect (Fig. 5e). We
then raised cellular levels of O-GlcNAc by inhibiting O-
GlcNAc hydrolase (OGA), which led to a small increase
in the expression of L1s, but not of TET1-unbound TEs
(Additional file 2: Figure S7C and D). The seemingly
conflicting outcomes of OGT depletion and OGA inhib-
ition likely reflect the broad and complex roles that
O-GlcNAc plays in chromatin regulation, with both acti-
vating and repressive outcomes [48, 49]. Nonetheless, it
remains possible that cycling of O-GlcNAc through
OGT and OGA plays a direct role in L1 silencing. To
test whether recruitment of SIN3A to L1s is involved in
their regulation, we used siRNA/shRNA-mediated deple-
tion of SIN3A (Fig. 5f ). This caused a 50–70% increase
on the expression levels of young L1s, whereas TEs
unbound by TET1 remained unaffected (Fig. 5g). More-
over, the effect on L1s was TET1-dependent, as the
upregulation observed on SIN3A KD samples was lost
when we knocked down both SIN3A and TET1, which
is in line with the TET1-dependent recruitment of
SIN3A to chromatin [28]. We also confirmed that
SIN3A-mediated L1 derepression involved full-length
elements and a concomitant increase of ORF1p protein
levels (Additional file 2: Figure S7A and B). This result
is, to the best of our knowledge, the first time that
SIN3A has been implicated in TE regulation. Interest-
ingly, SIN3A binding is also seen at the 5′ UTR of
human L1s in ESCs (Additional file 2: Figure S8), raising
the possibility that human L1s are also kept repressed by
TET-dependent deposition of SIN3A. Our data show
that there are TET-dependent repressive activities that
likely counteract oxidative DNA demethylation at L1
elements. Indeed, we show that, in a SIN3A-null con-
text, TET1 is a positive regulator of L1 expression. Our
work uncovers TET enzymes as epigenetic hubs with
dual roles in L1 regulation.
Discussion
We have shown that TET enzymes bind multiple TEs,
driving epigenetic alterations that impact on TE and
gene expression. Importantly, TET binding displays a
TE-specificity that implicates these enzymes in the
evolution of the host-TE relationship. Our detailed
bioinformatic characterisation revealed that there is no
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single epigenetic signature underlying TET1 binding
to TEs and instead TET1-bound TEs display a
myriad of epigenetic profiles that suggest distinct
functions. Namely, TETs bind exapted TEs that are
used by the host as CTCF sites (RLTR46) and en-
hancer elements (RLTR13D6 and others), potentially
involving TETs in the exaptation process. Indeed,
our data show that TET2 helps to control the
expression of genes interacting with TE-derived
enhancers, likely by maintaining a hypomethylated
state that is permissive for TF binding. TET2 bind-
ing to specific TEs seems to have conferred them
with an additional means for affecting gene expres-
sion that could have contributed to their exaptation
by the host genome (Fig. 6a).
At L1 elements, TET binding displays a striking
pattern whereby it targets exclusively the 5′ UTR of
young, active L1 clades. Moreover, the same pattern is
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apparent in human ESCs (as judged by the presence of
5hmC), which is suggestive of an evolutionarily conver-
gent mechanism that allows for L1 activation and expan-
sion. Parallel evolution of L1 silencing mechanisms is
also seen for KAP1 action, which targets and silences
older L1 elements in both mouse and human through
the binding of KRAB-ZFPs [16, 17]. Interestingly, none
of the young TET1/5hmC-enriched L1s are KAP1
targets. KAP1 binding leads to recruitment of SETDB1
and deposition of H3K9me3, which has been suggested
to impair TET1 binding at TEs [33]. Therefore, the
evolutionary escape of L1s from KAP1-mediated repres-
sion may have created permissive conditions for TET
binding, which in turn led to DNA demethylation
(Fig. 6b). Accordingly, we found that TET depletion
leads to increased methylation at the 5′ UTR of young
L1s. It is possible that the scale of this effect is
dependent on cell culture conditions, as these are known
to deeply affect DNA methylation levels in ESCs [21].
We note that L1 methylation levels in ESCs grown with
standard serum-containing medium, as used for all our
experiments, closely match those seen in blastocysts and
inner cell mass cells (Additional file 2: Figure S9). In
contrast, cells grown with the so-called ‘2i’ formulation
(with or without vitamin C) display substantially lower
L1 methylation levels (Additional file 2: Figure S9),
suggesting that the epigenetic modifiers targeting L1s in
2i cells differ to those acting in vivo.
Given that young L1s are derepressed in DNMT-null
ESCs [15, 16], TET-mediated DNA demethylation is
expected to activate L1 expression. However, our data
clearly show that TET depletion has no overall effect on
L1 expression levels, potentially arguing against a role of
TET recruitment in TE expansion. Mechanistically, the
maintenance of L1 expression upon TET-mediated
demethylation suggests that DNA methylation may not
play as prominent a role in the regulation of these TEs
as previously thought. It is possible that the L1 derepres-
sion seen in DNMT mutants [15, 16, 19] are independ-
ent of the enzymes’ catalytic activity [50], although ESCs
expressing catalytically inactive DNMT1 fail to repress
IAPs [51]. Alternatively, TETs may drive other catalytic-
ally independent alterations to chromatin that compen-
sate for changes in DNA methylation. In line with this
hypothesis, we found that TET2 depletion leads to a
reduction of H3K9me3 levels at L1s and that TET1
recruits the SIN3A co-repressor complex, which in turn
plays a role in L1 silencing. TET1 also recruits OGT to
L1s and our data indicate a possible role for O-GlcNAc
turnover in L1 repression. Interestingly, SIN3A is modi-
fied by OGT to synergistically repress transcription [52],
raising the possibility that the OGT-mediated and
SIN3A-mediated repressive effects on L1s are mechanis-
tically linked. However, OGT may also affect TE expres-
sion through RNA Pol II [53, 54] or other effects on
chromatin [48, 49].
Could TET-dependent repressive activities constitute a
host strategy for ensuring L1 silencing upon TET-
mediated DNA demethylation? In one possible evolution-
ary scenario, as a newly formed L1 clade (not necessarily
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Fig. 6 Models of TET-dependent regulation of TEs. a TE-derived ESC enhancers interact with highly expressed genes; TET binding is associated
with lower 5mC levels, increased NOS binding and higher gene expression, which could have played a role in the exaptation of these TEs by the
host genome. b L1 elements bound by KRAB-ZFP/KAP1 do not bind TETs and have high 5mC levels; loss of KAP1 binding (in currently active L1s
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the most recent ones) escaped from the repressive action
of KRAB-ZFP/KAP1, permissive TET-binding conditions
would have been created that would lead to DNA demeth-
ylation, contributing to L1 expansion (Fig. 6b). Selective
pressure to maintain genome stability could then have
driven the evolution of TET-dependent host strategies to
control L1 expansion, such as sequestration of epigenetic
silencing activities (e.g. SIN3A) by TET enzymes (Fig. 6b).
In this scenario, TETs would have served as ‘double
agents’ in an arms race between L1s and the host genome.
As each subsequent emerging L1 family escaped
KRAB-ZFP/KAP1 repression, the activating effects of
TET binding would have been dampened by the accom-
panying repressive activities. More effective and perman-
ent silencing of an active L1 family would then require the
recognition by a novel KRAB-ZFP [17]. In an alternative
scenario, the main selective pressures driving the interac-
tions between TETs and epigenetic silencers could have
come from elsewhere. Yet the added need to maintain
control of L1 expression during preimplantation could
have arguably re-enforced these epigenetic relationships
and further contributed to their evolution and fine-tuning.
It remains possible that in other cell types TET-
mediated control of DNA methylation regulates L1 tran-
scription due to differences in the underlying epigenome.
For example, TET1 and TET2 silencing during early ESC
differentiation may be important to ensure full L1
repression through DNA methylation. And in neurons,
where 5hmC levels are particularly high [55], TET-
mediated DNA demethylation could help drive the high
levels of L1 expression seen therein [56, 57].
Conclusions
We have unveiled several novel roles of TET enzymes in
the regulation of TEs, both catalytically dependent and
independent. TETs mediate DNA demethylation of
several TEs, but also serve as a hub for additional epi-
genetic activities, both of which impact on the evolu-
tion of the TE-host relationship. The intriguing dual
nature of TET action on L1 elements appears to re-
flect the competing interests of host and TEs, raising
new questions on TE-driven evolution of epigenetic
mechanisms.
Methods
ESC culture, gene knockdown and PUGNAc treatment
E14 ESCs were grown in feeder-free conditions using
DMEM-based medium with 15% FBS and 1000 U/mL
ESGRO LIF (Millipore). For shRNA-mediated gene
knockdown, ESCs were infected with viral particles
carrying pLKO.1 constructs harbouring gene-specific
shRNAs or a non-targeting sequence (Scr: CCTAAGG
TTAAGTCGCCCTCGCTC; shTET1: TTTCAACTCCG
ACGTAAATAT, TRCN0000341848; shTET2: TTCGG
AGGAGAAGGGTCATAA, TRCN0000250894). After
24 h, cells were selected with 10 μg/mL puromycin or
50 μg/mL hygromycin for 3–9 days (see ‘Results’). For
siRNA-mediated knockdown, cells were transfected
twice (second transfection two days after the first one)
with gene-specific (see below) or non-targeting siRNAs
(Dharmacon siGENOME Non-Targeting siRNA #2
Cat.D-001210-02-20) using Lipofectamine 3000 (Thermo
Scientific, Cat. L3000008) and collected four days post
transfection. Tet1 (Dharmacon siGENOME Mouse Tet1
Cat. D-062861-01-0020) and Sin3a siRNAs (Dharmacon
Custom siRNA ON-TARGET Cat. CTM-220747,
sequence: gctgttccgattgtccttaaa) were used at 125 nM,
whereas Ogt esiRNAs (Sigma-Aldrich, Cat. EMU006701)
were used at 50 nM. Knockdown was confirmed by
RT-qPCR and western blot. PUGNAc (Sigma-Aldrich,
Cat. A7229) treatment was performed either with 100 μM
of DMSO-dissolved PUGNAc or matched amount of
DMSO in control conditions and its efficiency was tested
by western blot. A list of antibodies used can be found in
Additional file 3.
RNA isolation, RT-qPCR and northern blot
RNA was extracted using Quick-RNA™ MiniPrep (Zymo
Research D7003) and DNAse treated in-column either
with the DNAse provided on the kit or with the TURBO
DNA-free™ Kit (Ambion, AM1907). RNA (1 μg) was
retrotranscribed using SuperScript® III Reverse Transcript-
ase (Invitrogen, Cat. 18080044) and the cDNA was diluted
1/10 for qPCRs using MESA BLUE MasterMix (Euroge-
nentec, 10-SY2X-03 +NRWOUB) on a LightCycler® 480
Instrument II (Roche). A list of primers used can be found
in Additional file 3: Table S2. For northern blotting, 0.5 μg
of glyoxylated total RNA was separated on a 1.2% BPTE
gel, then blotted and probed as described in [58]. RNA
probes were amplified from mouse genomic DNA using
the primers detailed in Additional file 3.
Chromatin immunoprecipitation
ChIP was performed as described in [59], with modifica-
tions. For the detection of TFs (TET1, TET2, SIN3A,
OGT, OCT4), cells were fixed with an initial cross-
linking step of 45 min with 2 mM Di(N-succinimidyl)
glutarate (Sigma-Aldrich Cat. 80424) in PBS at room
temperature, followed by a PBS wash and a second
fixation step of 12 min with 1% formaldehyde in DMEM.
For histone ChIPs (H3K4me3, H3K9me3, H3) a single
cross-linking step with 1% formaldehyde for 15 min was
used. After quenching with glycine, washes and lysis,
chromatin was sonicated using a Bioruptor Pico from
Diagenode, on a 30 s on/off cycle for 12 (TFs) or eight
(histones) cycles. Immunoprecipitation was performed
using 150 μg of chromatin and 7.5 μg of antibody (TFs)
or 30 μg of chromatin and 5 μg of antibody (histones).
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Final DNA purification was performed using the Gene-
JET PCR Purification Kit (Thermo Scientific. Cat.
K0701) and elution in 80 μL of elution buffer. This was
diluted 1/10 and analysed by qPCR, using the KAPA
SYBR® FAST Roche LightCycler® 480 2X qPCR Master
Mix (Kapa Biosistems, Cat. KK4611). A list of antibodies
and primers used can be found in Additional file 3.
RNA-seq and small RNA-seq
Ribosomal RNA-depleted RNA-seq libraries were
prepared from 400–600 ng of total RNA using the
low input ScriptSeq Complete Gold Kit (Epicentre).
For small RNA-seq, RNA was isolated with QIAzol
(QIAGEN) and libraries prepared from 400–600 ng of
RNA using the NEBNext small RNA library prep kit
(NEB), followed by size selection (~120–150 bp,
including adaptors) using gel extraction. Libraries
were sequenced on an Illumina NextSeq 500 with
single-end 75 bp reads.
Oxidative bisulphite sequencing
Deep sequencing of PCR products from BS-converted and
oxBS-converted DNA was performed as previously de-
scribed [44]. Briefly, precipitated DNA (without glycogen)
was resuspended in water and further purified using Mi-
cro Bio-Spin columns (Bio-Rad), after which half of the
DNA was oxidised with 15 mM KRuO4 (Alpha Aesar) in
0.5 M NaOH for 1 h. Following bisulphite conversion of
both DNA fractions with the EpiTect Bisulfite kit (QIA-
GEN), a two-step PCR amplification was used: a first PCR
amplifies the region of interest and adds part of the
sequencing adaptors; a second PCR on pooled amplicons
then completes the adaptors and adds sample barcodes,
allowing for multiplexing (see primers in Additional file
3). Paired-end sequencing of pooled samples was done
using an Illumina MiSeq.
Individual L1 elements
For RT-qPCR and oxBS analysis of individual L1s in the
mouse reference genome, assays were first designed for
several full-length elements with uniquely mapped reads
and high 5hmC levels in TAB-seq data. We then
selected elements whose RT and oxBS amplicons were
validated by Sanger sequencing and for which the abun-
dance in genomic DNA was close to that of single copy
genes, as judged by qPCR. Elements have the following
mm9 coordinates: chr2:125230942–125237372 (HL1-2;
contains L1Tf monomers), chr5:70814798–70821450
(HL1-6; L1Tf monomers), chr6:107895070–107901677
(HL1-7; L1A monomers).
High-throughput sequencing data processing
External datasets were downloaded from GEO (Additional
file 4). Reads were trimmed using Trim_galore! v0.3.3 with
default parameters, except for small RNA-seq, where the
options ‘-q 0 –length 15’ were used. Alignments were per-
formed either to the whole mouse genome (mm9), to the
L1Orl sequence (accession number D84391) or the L1.4 se-
quence (accession number L19092). ChIP-seq and small
RNA-seq data were aligned using Bowtie2 v2.1.0 [60] with
default parameters, which assigns reads with multiple
hits of equal mapping quality to one of those
locations at random (inclusive mapping). To obtain
uniquely mapped data, the output SAM file was fil-
tered using a custom script. ChIP-seq peak detection
was performed using the MACS algorithm imple-
mented within Seqmonk. RNA-seq data were aligned
using Tophat v2.0.9 [61] with -g 1 option, which
yields inclusive mapping. BS-seq and TAB-seq data were
aligned to representative L1 elements (as above) using Bis-
mark [62]; for genome-wide analysis, processed CpG calls
from uniquely mapped data were obtained directly from
GEO (see Additional file 4). OxBS data were aligned with
Bismark to a custom genome containing the amplicon se-
quences; only CpGs covered by at least 100 reads were
used to calculate 5mC/5hmC levels.
TET1 ChIP-seq analysis
To detect TE classes that were enriched for TET1
binding events, the number of TET1 peaks (from
unique or inclusive mapping) overlapping each TE
class (using the Repeatmasker annotation) were
summed. This was compared with the overlaps ob-
tained using a matched list of regions (equal number
and lengths than the TET1 peaks) randomly distrib-
uted anywhere in the genome (for inclusive mapping)
or within mappable regions of the genome, as defined
by the uniqueome [63] (for unique mapping).
RNA-seq analysis
Raw read counts for each gene or repeat (from
RepeatMasker annotation) were generated in Seqmonk
with the RNA-seq quantitation pipeline. Reads from
repeats belonging to the same class were pooled.
DESeq2 was used for differential expression analysis
and for generating normalised gene and repeat ex-
pression values. To couple TE-derived enhancers to
gene expression values, promoter capture Hi-C data
from ESCs [37], as processed by CHiCAGO [64]
(kindly provided by Paula Freire-Pritchett, Babraham
Institute), was used.
Additional files
Additional file 1: List of TET1-bound TEs using either unique or inclusive
mapping. (XLSX 51 kb)
Additional file 2: Figures S1 to S9. (PDF 1217 kb)
de la Rica et al. Genome Biology  (2016) 17:234 Page 12 of 14
Additional file 3: List of antibodies and primers. (XLSX 34 kb)
Additional file 4: Accession numbers of external datasets. (XLSX 41 kb)
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